Scenario:
A mid-stage biotech developing a novel therapeutic candidate was approaching a BLA submission with a fragmented regulatory history spanning multiple years and contributors.
Internal knowledge gaps and disorganized documentation threatened to create significant roadblocks at a critical milestone...